|
Device | Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System |
Generic Name | Pulmonary valve prosthesis percutaneously delivered |
Applicant | Edwards Lifesciences, LLC One Edwards Way Irvine, CA 92614 |
PMA Number | P200015 |
Date Received | 03/09/2020 |
Decision Date | 08/31/2020 |
Product Code |
NPV |
Docket Number | 20M-1835 |
Notice Date | 09/02/2020 |
Advisory Committee |
Cardiovascular |
Clinical Trials | NCT02744677
|
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System with Commander Delivery System is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional right ventricular outflow tract (RVOT) conduit or surgical bioprosthetic valve in the pulmonic position with greater than or equal to moderate regurgitation and/or a mean RVOT gradient of greater than or equal to 35 mmHg. |
Approval Order | Approval Order |
Summary | Summary of Safety and Effectiveness |
Labeling | Labeling Labeling Part 2 |
Post-Approval Study | Show Report Schedule and Study Progress |
Supplements: |
S009 S020 S021 S032 S012 S013 S014 S015 S016 S005 S006 S007 S035 S036 S037 S038 S039 S040 S041 S046 S024 S026 S027 S028 S029 S030 S017 S010 S042 S033 S034 S008 S031 S022 S023 S001 S002 S003 S004 S018 S019 S011 S049 S050 S051 S052 S053 S047 S048 S043 S044 S045 |